RDY drreddys.com: Indikator likuiditas cepet

Dr. Reddy's Laboratories (RDY) is globally valued as a reliable supplier of affordable generics. The current ratio on GURU.Markets reflects solvency dynamics, where the value 1.46 serves as the baseline indicator. Business development relies on a strong team of R&D chemists, while the scaling of Asian production facilities effectively reduces costs, increasing the holding's overall operating margin.

The quick ratio measures a company's ability to instantaneously settle short-term liabilities without liquidating inventory. By analyzing fluctuations in the quick ratio, an investor assesses the ratio of cash and accounts receivable to current debts. A decline in this metric signals increasing financial vulnerability. For Dr. Reddy's Laboratories (RDY), this is critical, as the large-scale robotization of plants requires a stable operating reserve.